Cite
HARVARD Citation
Reckamp, K. et al. (2015). Randomized phase 2 trial of erlotinib in combination with high‐dose celecoxib or placebo in patients with advanced non‐small cell lung cancer. Cancer. 121 (18), pp. 3298-3306. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Reckamp, K. et al. (2015). Randomized phase 2 trial of erlotinib in combination with high‐dose celecoxib or placebo in patients with advanced non‐small cell lung cancer. Cancer. 121 (18), pp. 3298-3306. [Online].